Discontinued — last reported Q4 '25
Acquisitions
InvestingEli Lilly Acquisitions remained flat by 0.0% to $165.25M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 30.3%, from $236.93M to $165.25M. Over 4 years (FY 2021 to FY 2025), Acquisitions shows a downward trend with a -3.0% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryGrowth
SignalContext dependent
VolatilityVolatile
First reportedQ1 2015
Last reportedQ4 2025
How to read this metric
Large outflows indicate a period of aggressive expansion and consolidation, which carries integration risk but potential for high growth.
Detailed definition
The net cash paid to acquire other businesses, calculated as the purchase price minus any cash already held by the targe...
Peer comparison
Lumpy and episodic across the semiconductor industry, often occurring in cycles of industry consolidation.
Metric ID:
cf_acquisitionsHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $327.20M | $261.08M | $261.08M | $261.08M | $261.08M | $236.93M | $236.93M | $236.93M | $236.93M | $165.25M | $165.25M | $165.25M | $165.25M |
| QoQ Change | — | — | — | — | — | — | — | -20.2% | +0.0% | +0.0% | +0.0% | -9.3% | +0.0% | +0.0% | +0.0% | -30.3% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | -20.2% | -9.3% | -9.3% | -9.3% | -9.3% | -30.3% | -30.3% | -30.3% | -30.3% |
Range$0.00 – $327.20M
Avg YoY Growth-19.8%
Median YoY Growth-20.2%
Current Streak3 quarters growth
Acquisitions at Other Companies
Frequently Asked Questions
- What is Eli Lilly's acquisitions?
- Eli Lilly (LLY) reported acquisitions of $165.25M in Q4 2025.
- How has Eli Lilly's acquisitions changed year-over-year?
- Eli Lilly's acquisitions decreased by 30.3% year-over-year, from $236.93M to $165.25M.
- What is the long-term trend for Eli Lilly's acquisitions?
- Over 4 years (2021 to 2025), Eli Lilly's acquisitions has grown at a -3.0% compound annual growth rate (CAGR), from $747.40M to $661.00M.
- What does acquisitions mean?
- The total cash spent to buy other companies, after subtracting the cash those companies already had.